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Identity 
Other names: 80K-L, MACS, PKCSL, PRKCSL 




The MARCKS gene is located 6q21 
(114178527..114184652). 
Transcription 
The transcription product is 6,1 kb with 2 exons.  
The mRNA has 996 bp open reading frame. The 
promoter region has no TATA box and contained 
multiple transcription initiation sites in a region 
spanning 57 base pairs (bp) (Harlan et al., 1991). 
Protein 
Note 
MARCKS was cloned as a protein kinase C (PKC) 
substrate.  
The protein binds plasma membrane via N-terminus 
myristoylation and the phosphorylation site domain 
(PSD), which is also called effector domain (ED), with 
electrostatic interaction. MARCKS interacts with actin, 
calmodulin, PIP2 on the PSD. 
 
Figure 1. A) MARCKS location on chromosome 6 is indicated. MARCKS gene starts at 114178527 and ends at 114184652. B) 
MARCKS gene is indicated. It has two exons and one intron. 
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Figure 2. A) MARCKS phosphorylation site domain (PSD (also called effector domain (ED))) is shown. It is mainly consisted of basic 
amino asids (K and R) and has serin residues phosphorylatable by PKC (159, 163 and 170) and by ROCK (at least 159). B) Dephospho 




Phosphorylation of MARCKS is instrumental in its 
redistribution. MARCKS possesses a basic 
phosphorylation site domain (PSD). Phosphorylation of 
this PSD domain prevents the electrostatic interaction 
of the effector region of the MARCKS to the plasma 
membrane (George and Blackshear, 1992; Taniguchi 
and Manenti, 1993; Kim et al., 1994). 
Expression 
The MARCKS protein is highly expressed in the brain, 
spleen, and lung, and is virtually absent in skeletal 
muscle and liver in adult animal (Stumpo et al., 1989; 
Blackshear et al., 1986; Albert et al., 1986). 
Localisation 
Dephosphorylated and phosphorylated MARCKS are 
located at plasma membrane and in cytosol, 
respectively. 
Function 
MARCKS closs-links actin filament (Yarmola et al., 
2001) and changes cell morphology responsing to cell 
stimulations in its phosphorylation/dephosphorylation-
dependent manner (Tanabe et al., 2012). MARCKS 
participates in thrombin-induced noradrenaline release 
from platelets (Elzagallaai et al., 2001) and PMA- or 
bonbesin-induced neurotensin release from BON cells 
(Li et al., 2005). MARCKS regulates the proliferation  
and/or movement of some type of cells (Brooks et 
al.,1996; Zhao et al., 2000; Weimer et al., 2009). 
MARCKS plays a vital role in the normal 
developmental processes of neurulation, hemisphere 
fusion, forebrain commissure formation, and formation 
of cortical and retinal laminations (Stumpo et al., 
1995). Long-term potentiation (LTP) is significantly 
impaired in the mossy fiber-CA3 pathway in MARCKS 
heterozygous mutant mice (Hussain et al., 2006). 
Homology 
Human MARCKS protein (332 amino acids) was 
approximately 89, 74, and 59% identical to the bovine, 
mouse, and chicken proteins. N-terminal domain and 
phosphorylation site domain (PSD) are highly-




In MARCKS over expressed human tumor-derived 
choroidal melanoma cells (OCM-1) the growth was 
reduced by 35-40% when compared with control cells 
(Manenti et al., 1998). In a highly motile melanoma 
cell line WM-1617 melanoma cells nonphosphorylated 
MARCKS works as an adhesion stabilizer (Estrada-
Bernal et al., 2009). 






Atlas Genet Cytogenet Oncol Haematol. 2013; 17(4)  268 
Alzheimer disease (AD) 
Note 
PKC-induced phosphorylation of MARCKS in cortical 
neurons in AD brains was weaker than that in control 
brains. However, phosphorylation of MARCKS was 
detected in microglia and dystrophic neurites within 
neuritic plaques (Kimura et al., 2000). In microglia 
amyloid β induces phosphorylation of MARCKS 
through mitogen-activatd protein kinase (MAPK) 
(Hasegawa et al., 2001) and PKCδ (Nakai et al., 2001). 
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